
Sign up to save your podcasts
Or


David Ricks, Eli Lilly Chairman & CEO, discusses the drugmaker’s Covid-19 antibody therapy that was granted emergency-use authorization in the U.S. Subadra Rajappa, Societe Generale Head of U.S. Rates Strategy, sees a departure from bonds into risky assets with a lot of cash on the sidelines that needs to be put to work. Kathy Hochul, New York Lieutenant Governor, says having a vaccine does not take the pressure off of further stimulus at all. Sam Stovall, CFRA Chief Investment Strategist, says Wall Street is looking beyond a coronavirus spike with vaccine developments appearing positive.
See omnystudio.com/listener for privacy information.
By Bloomberg3.9
11081,108 ratings
David Ricks, Eli Lilly Chairman & CEO, discusses the drugmaker’s Covid-19 antibody therapy that was granted emergency-use authorization in the U.S. Subadra Rajappa, Societe Generale Head of U.S. Rates Strategy, sees a departure from bonds into risky assets with a lot of cash on the sidelines that needs to be put to work. Kathy Hochul, New York Lieutenant Governor, says having a vaccine does not take the pressure off of further stimulus at all. Sam Stovall, CFRA Chief Investment Strategist, says Wall Street is looking beyond a coronavirus spike with vaccine developments appearing positive.
See omnystudio.com/listener for privacy information.

980 Listeners

409 Listeners

2,190 Listeners

1,997 Listeners

433 Listeners

970 Listeners

193 Listeners

186 Listeners

69 Listeners

1,315 Listeners

65 Listeners

81 Listeners

30 Listeners

62 Listeners

4 Listeners

58 Listeners

233 Listeners

228 Listeners

62 Listeners

86 Listeners

82 Listeners

81 Listeners

81 Listeners

407 Listeners

21 Listeners

12 Listeners

7 Listeners

2 Listeners

115 Listeners

24 Listeners